(Report ID: 150064) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,583 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 14,237 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 150064 | Jun, 28, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug |
Medroxyprogesterone Acetate |
Premarin |
Provera |
| Name |
Breast Cancer Female |
Results from eHealthMe: 14,237 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Breast Cancer Female | 3,557 (24.98%) |
Death: 0
Cancer: 1,225 (93.87% of total reports)
| Name | Count (% of total reports) |
1 | Breast Cancer | 662 (50.73%) |
2 | Breast Cancer Metastatic | 385 (29.50%) |
3 | Breast Cancer Female | 56 (4.29%) |
4 | Deep Vein Thrombosis | 47 (3.60%) |
5 | Pulmonary Embolism | 30 (2.30%) |
6 | Depression | 27 (2.07%) |
7 | Cerebrovascular Accident | 27 (2.07%) |
8 | Breast Cancer Recurrent | 26 (1.99%) |
9 | Contralateral Breast Cancer | 24 (1.84%) |
10 | Breast Cancer In Situ | 24 (1.84%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Prempro | 1,064 |
2 | Cycrin | 210 |
3 | Estrace | 88 |
4 | Estraderm | 52 |
5 | Conjugated Estrogens | 36 |
6 | Fosamax | 31 |
7 | Prometrium | 28 |
8 | Estradiol | 25 |
9 | Climara | 23 |
10 | Estratab | 23 |
Death: 18 (0.13% of total reports)
Cancer: 11,320 (79.51% of total reports)
| Name | Count (% of total reports) |
1 | Breast Cancer | 5,465 (38.39%) |
2 | Breast Cancer Female | 3,557 (24.98%) |
3 | Breast Cancer Metastatic | 1,017 (7.14%) |
4 | Oestrogen Receptor Assay Positive | 786 (5.52%) |
5 | Progesterone Receptor Assay Positive | 677 (4.76%) |
6 | Breast Cancer In Situ | 427 (3.00%) |
7 | Ovarian Cancer | 344 (2.42%) |
8 | Nausea | 243 (1.71%) |
9 | Cerebrovascular Accident | 229 (1.61%) |
10 | Deep Vein Thrombosis | 209 (1.47%) |
| Name | Count |
1 | Prempro | 6,848 |
2 | Cycrin | 1,798 |
3 | Estrace | 1,067 |
4 | Conjugated Estrogens | 495 |
5 | Estradiol | 472 |
6 | Estraderm | 455 |
7 | Synthroid | 382 |
8 | Aspirin | 261 |
9 | Activella | 260 |
10 | Climara | 259 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
